跳至主要内容
临床试验/NCT05689515
NCT05689515已完成不适用

PL4Y: A Pilot Randomized Control Trial to Study the Feasibility of Positive Links for Youth Care Engagement Intervention

The University of Texas Health Science Center at San Antonio2 个研究点 分布在 1 个国家目标入组 29 人开始时间: 2023年2月2日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
29
试验地点
2
主要终点
Viral plasma load measurement

研究概览

简要总结

A small pilot study to assess feasibility and acceptability of the PL4Y intervention.

详细描述

After completing enrollment and informed consent, participants will be randomly assigned to PL4Y in a 2:1 fashion (intervention:control) with a target enrollment of 40 receiving the intervention and 20 in the control arm for a total of 60 participants. There is no blinding in this study protocol.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 29 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Confirmed HIV infection
  • Recent diagnosis of HIV (within the past 6 months) OR be virologically unsuppressed (>1000 copies/ml) OR disengaged from HIV care (< 2 visits/last 12 months > 90 days apart)

排除标准

  • Cannot consent
  • Unwilling to come to visits
  • Unwilling to be in San Antonio for a year

研究组 & 干预措施

Mobile Health App group

Experimental

Mobile health app to increase rates of engagement in care in youths living with HIV

干预措施: Mobile health app (Behavioral)

Control group

No Intervention

Standard of care for youths living with HIV

结局指标

主要结局

Viral plasma load measurement

时间窗: 12 months

Virologic suppression is the primary goal of HIV treatment. Virologic failure is defined as a measurement over 200 copies per mL by the Department of Health and Human Services, and is the primary determinant of successful HIV control.

Completion of Feasibility Survey

时间窗: 12 months

Feasibility survey completion by participants regarding usability of the PL4Y intervention

Number of Participants With Undetectable Viral Load

时间窗: 12 months

Virologic suppression is the primary goal of HIV treatment. Virologic failure is defined as a measurement over 200 copies per mL by the Department of Health and Human Services, and is the primary determinant of successful HIV control. This outcome is categorized as: Undetectable (VL \<200 at 12 months)

Feasibility Survey Completion

时间窗: 6 and 12 month time points

Feasibility of the intervention assessed using a participant-completed survey at 6 and 12 months. Measured as number of participants that completed the survey in the arm that received the intervention only.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验